What separates the ASTM document from the needs of the pharma industry?
A large sample set is required that spans between 3 to 5 SD of all constituents
- Generating these OOS samples is difficult as they should be prepared using the same equipment as used in the process. For the pharma companies this represents large $$$
- If PAT is to be used upon product launch, the amount of active ingredient required may exceed the ROI